On 29 January 2018, following the request made by the Commission and eight Member States and pursuant to Article 6(1) of the above-mentioned Council Decision, the Council requested an assessment of the risks caused by the use, manufacture and trafficking of the new psychoactive substances N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide (cyclopropylfentanyl) and 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), the involvement of organised crime and the possible consequences of control measures introduced on this substance.
Vijeće je 29. siječnja 2018. na zahtjev Komisije i osam država članica te u skladu s člankom 6. stavkom 1. prethodno navedene Odluke Vijeća zatražilo procjenu rizika prouzročenih uporabom i proizvodnjom novih psihoaktivnih tvari N-fenil-N-[1-(2-feniletil)piperidin-4-il]ciklopropankarboksamid (ciklopropil-fentanil) i 2-metoksi-N-fenil-N-[1-(2-feniletil)piperidin-4-il]acetamid (metoksiacetil-fentanil) i trgovinom njima te procjenu uključenosti organiziranog kriminala i mogućih posljedica kontrolnih mjera uvedenih za te tvari.